NASDAQ
Boston Therapeutics, Inc. (BTHE) has a free cash flow growth of -299.11% as of Friday, May 29, 2026. This represents a 140.19% decrease compared to its 12-month average of -124.53%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.